Mitzi Nagarkatti to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Mitzi Nagarkatti has written about Drug Evaluation, Preclinical.
Connection Strength
0.252
-
Resveratrol (3, 5, 4'-Trihydroxy-trans-Stilbene) Attenuates a Mouse Model of Multiple Sclerosis by Altering the miR-124/Sphingosine Kinase 1 Axis in Encephalitogenic T Cells in the Brain. J Neuroimmune Pharmacol. 2019 09; 14(3):462-477.
Score: 0.157
-
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood. 2002 Jul 15; 100(2):627-34.
Score: 0.049
-
Discovery of anti-infective adipostatins through bioactivity-guided isolation and heterologous expression of a type III polyketide synthase. Bioorg Chem. 2021 07; 112:104925.
Score: 0.045